$0.495
-0.309 (-62.50%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
LYRA Prediction & Forecast by Similar Chart Analysis
Alphio's LYRA stock price prediction model matches the current Lyra Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.50 (+0.40%). The 1-week path is $0.51 (+2.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Lyra Therapeutics Inc Stock?
Lyra Therapeutics Inc (LYRA) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The company's weak financial performance, lack of significant trading trends, and absence of strong positive catalysts suggest that this stock does not align with the user's investment goals. While the technical indicators show some neutral to slightly positive signals, they are not compelling enough to justify a buy decision at this time.
LYRA stock price ended at $0.50 on Monday, after losing -62.50%
Lyra Therapeutics Inc (LYRA) last closed at $0.495, losing -62.50%. These facts feed the 1-day and 1-week LYRA price prediction above.
Forecast Drivers
Lyra Therapeutics Inc (LYRA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches LYRA, ranked by similarity.
Seasonality analysis for LYRA
Historically the probability of a positive August return for LYRA is 0.00%. March offers the highest probability of a positive month at 38.46%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.